{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T07:35:01Z","timestamp":1770536101287,"version":"3.49.0"},"reference-count":16,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>The use of lipid-based nanosystems, including lipid nanoparticles (solid lipid nanoparticles\u2014SLN, and nanostructured lipid carriers\u2014NLC), nanoemulsions, and liposomes, among others, is widespread [...]<\/jats:p>","DOI":"10.3390\/pharmaceutics13050708","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T22:46:14Z","timestamp":1620859574000},"page":"708","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preclinical Evaluation of Lipid-Based Nanosystems"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6923-0232","authenticated-orcid":false,"given":"Ana Catarina","family":"Silva","sequence":"first","affiliation":[{"name":"UCIBIO\/REQUIMTE, MEDTECH, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"},{"name":"FP-ENAS (UFP Energy, Environment and Health Research Unit), CEBIMED (Biomedical Research Centre), Faculty of Health Sciences, University Fernando Pessoa, 4249-004 Porto, Portugal"}]},{"given":"Jos\u00e9 Manuel","family":"Sousa Lobo","sequence":"additional","affiliation":[{"name":"UCIBIO\/REQUIMTE, MEDTECH, Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Pena-Rodr\u00edguez, E., Lajarin-Reinares, M., Mata-Ventosa, A., P\u00e9rez-Torras, S., and Fern\u00e1ndez-Campos, F. (2021). Dexamethasone-Loaded Lipomers: Development, Characterization, and Skin Biodistribution Studies. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040533"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Nair, A.B., Shah, J., Al-Dhubiab, B.E., Jacob, S., Patel, S.S., Venugopala, K.N., Morsy, M.A., Gupta, S., Attimarad, M., and Sreeharsha, N. (2021). Clarithromycin Solid Lipid Nanoparticles for Topical Ocular Therapy: Optimization, Evaluation and In Vivo Studies. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040523"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kubackova, J., Holas, O., Zbytovska, J., Vranikova, B., Zeng, G., Pavek, P., and Mullertz, A. (2021). Oligonucleotide Delivery across the Caco-2 Monolayer: The Design and Evaluation of Self-Emulsifying Drug Delivery Systems (SEDDS). Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040459"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Guillot, A.J., Jornet-Moll\u00e1, E., Landsberg, N., Mili\u00e1n-Guimer\u00e1, C., Montesinos, M.C., Garrigues, T.M., and Melero, A. (2021). Cyanocobalamin Ultraflexible Lipid Vesicles: Characterization and In Vitro Evaluation of Drug-Skin Depth Profiles. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13030418"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Langeveld, S.A.G., Beekers, I., Collado-Lara, G., van der Steen, A.F.W., de Jong, N., and Kooiman, K. (2021). The Impact of Lipid Handling and Phase Distribution on the Acoustic Behavior of Microbubbles. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13010119"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Valdivia, L., Garc\u00eda-Hevia, L., Ba\u00f1obre-L\u00f3pez, M., Gallo, J., Valiente, R., and L\u00f3pez Fanarraga, M. (2021). Solid Lipid Particles for Lung Metastasis Treatment. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13010093"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Alkhalidi, H.M., Hosny, K.M., and Rizg, W.Y. (2021). Oral Gel Loaded by Fluconazole\u2012Sesame Oil Nanotransfersomes: Development, Optimization, and Assessment of Antifungal Activity. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13010027"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hernando, S., Herran, E., Hernandez, R.M., and Igartua, M. (2020). Nanostructured Lipid Carriers Made of \u03a9-3 Polyunsaturated Fatty Acids: In Vitro Evaluation of Emerging Nanocarriers to Treat Neurodegenerative Diseases. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12100928"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Mazonde, P., Khamanga, S.M.M., and Walker, R.B. (2020). Design, Optimization, Manufacture and Characterization of Efavirenz-Loaded Flaxseed Oil Nanoemulsions. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12090797"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Farzan, M., Qu\u00e9batte, G., Strittmatter, K., Hilty, F.M., Schoelkopf, J., Huwyler, J., and Puchkov, M. (2020). Spontaneous In Situ Formation of Liposomes from Inert Porous Microparticles for Oral Drug Delivery. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080777"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Kari, O.K., Tavakoli, S., Parkkila, P., Baan, S., Savolainen, R., Ruoslahti, T., Johansson, N.G., Ndika, J., Alenius, H., and Viitala, T. (2020). Light-Activated Liposomes Coated with Hyaluronic Acid as a Potential Drug Delivery System. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080763"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Almasri, R., Joyce, P., Schultz, H.B., Thomas, N., Bremmell, K.E., and Prestidge, C.A. (2020). Porous Nanostructure, Lipid Composition, and Degree of Drug Supersaturation Modulate In Vitro Fenofibrate Solubilization in Silica-Lipid Hybrids. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12070687"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Scavo, M.P., Cutrignelli, A., Depalo, N., Fanizza, E., Laquintana, V., Gasparini, G., Giannelli, G., and Denora, N. (2020). Effectiveness of a Controlled 5-FU Delivery Based on FZD10 Antibody-Conjugated Liposomes in Colorectal Cancer In vitro Models. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12070650"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Belfiore, L., Saunders, D.N., Ranson, M., and Vine, K.L. (2020). N-Alkylisatin-Loaded Liposomes Target the Urokinase Plasminogen Activator System in Breast Cancer. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12070641"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Cunha, S., Costa, C.P., Loureiro, J.A., Alves, J., Peixoto, A.F., Forbes, B., Lobo, J.M.S., and Silva, A.C. (2020). Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12070599"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hart, K., Harvey, M., Tang, M., Wu, Z., and Cave, G. (2021). Liposomes to Augment Dialysis in Preclinical Models: A Structured Review. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13030395"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/5\/708\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:59:48Z","timestamp":1760162388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/5\/708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":16,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["pharmaceutics13050708"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13050708","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]}}}